January 23, 2016
Hikma’s buying of Roxane from Boehringer general meeting in February
Hikma Pharmaceuticals has prepared a combined Prospectus that contains the formal notice of meeting for the general meeting, to be…
pharmaceutical daily
Pharmaceuticals, Biotechnology and Life Sciences
January 21, 2016
Five charged in U.S. with stealing secrects from GlaxoSmithKline
Five charged in U.S. with stealing secrects from GlaxoSmithKline
January 21, 2016
Glenmark Pharmaceuticals entering $130M market with two new generic medicines
Glenmark Pharmaceuticals entering $130M market with Actavis’ Potassium Cholire capsules and generics of Warner Chilcott’s Loestrin tablets
January 21, 2016
Indian Natco to sell Bristol-Myer Squibb’s hepatitis C medicine in 112 countries
Indian pharmaceutical company Natco Pharma Limited has signed a nonexclusive, royalty free licensing agreement with the Medicines Patent Pool and…
January 20, 2016
Ex-drug CEO Shkreli plans to replace lawyers
Former drug executive Martin Shkreli plans to hire new legal counsel to represent him against U.S. charges that he defrauded investors at his former hedge fund and a pharmaceutical company he headed, Shkreli’s current lawyers said.
January 20, 2016
German Biofrontera leaving London Stock Exchange
Biofrontera, the biopharmaceutical company focusing on sun-induced skin cancer, has decided to cancel the admission of its ordinary shares to trading…
January 18, 2016
Eurostars grant awarded to international consortium including Abzena company, Antitope, for development of novel treatment for clotting disorders
Eurostars grant awarded to international consortium including Abzena company, Antitope, for development of novel treatment for clotting disorders
January 15, 2016
French drug trial disaster leaves one brain dead, five injured
One person has been left brain dead and five others have been hospitalised after taking part in a clinical trial in France of an experimental drug made by Portuguese drug company Bial, French Health Minister Marisol Touraine said on Friday.
January 15, 2016
Premaitha Health CEO: “NSC recommendation a key milestone for prenatal testing in UK”
Premaitha Health PLC welcomes the UK National Screening Committee’s (NSC) recommendation to routinely offer NIPT testing on the NHS to…
January 12, 2016
Drugmaker Shire to buy Baxalta for $32 billion after six-month pursuit
Drugmaker Shire Plc clinched its six-month pursuit of Baxalta International Inc on Monday with an agreed $32 billion (22 billion pound) cash and stock offer, catapulting it to a leading position in treating rare diseases.